Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
A recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for HPV serum antibodies and HPV DNA. Serology for HPV 16 VLPs, E6, and E7 antibodies was performed on 49 of the 66 cases which were HPV-negative and a sample of 48 of the 866 cases which were HPV-positive in the original study.
Moreover, 55 of the 66 formerly HPV-negative biopsies were also reanalyzed by a sandwich procedure in which the outer sections in a series of sections are used for histological review, while the inner sections are assayed by three different HPV PCR assays targeting different open reading frames (ORFs). No significant difference was found in serology for HPV 16 proteins between the cases that were originally HPV PCR-negative and -positive. Type-specific E7 PCR for 14 high-risk HPV types detected HPV DNA in 38 (69 per cent) of the 55 originally HPV-negative and amplifiable specimens. The HPV types detected were 16, 18, 31, 33, 39, 45, 52, and 58. Two (4 per cent) additional cases were only HPV DNA-positive by E1 and/or L1 consensus PCR. Histological analysis of the 55 specimens revealed that 21 were qualitatively inadequate. Only two of the 34 adequate samples were HPV-negative on all PCR tests, as against 13 of the 21 that were inadequate ( p< 0.001).
Combining the data from this and the previous study and excluding inadequate specimens, the worldwide HPV prevalence in cervical carcinomas is 99.7 per cent. The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer. The extreme rarity of HPV-negative cancers reinforces the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020.Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market.
The average age of the patients was 55·5 years (SD 13·1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT-PCR. 50 (51%) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient).
According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneumothorax. 17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure.The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome. In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia. Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection.National Key R&D Program of China.
AFLP: a new technique for DNA fingerprinting.
A novel DNA fingerprinting technique called AFLP is described. The AFLP technique is based on the selective PCR amplification of restriction fragments from a total digest of genomic DNA. The technique involves three steps: (i) restriction of the DNA and ligation of oligonucleotide adapters, (ii) selective amplification of sets of restriction fragments, and (iii) gel analysis of the amplified fragments.
PCR amplification of restriction fragments is achieved by using the adapter and restriction site sequence as target sites for primer annealing. The selective amplification is achieved by the use of primers that extend into the restriction fragments, amplifying only those fragments in which the primer extensions match the nucleotides flanking the restriction sites. Using this method, sets of restriction fragments may be visualized by PCR without knowledge of nucleotide sequence. The method allows the specific co-amplification of high numbers of restriction fragments. The number of fragments that can be analyzed simultaneously, however, is dependent on the resolution of the detection system. Typically 50-100 restriction fragments are amplified and detected on denaturing polyacrylamide gels. The AFLP technique provides a novel and very powerful DNA fingerprinting technique for DNAs of any origin or complexity.
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.
Accurate normalization is an absolute prerequisite for correct measurement of gene expression. For quantitative real-time reverse transcription-PCR (RT-PCR), the most commonly used normalization strategy involves standardization to a single constitutively expressed control gene. However, in recent years, it has become clear that no single gene is constitutively expressed in all cell types and under all experimental conditions, implying that the expression stability of the intended control gene has to be verified before each experiment.
We outline a novel, innovative, and robust strategy to identify stably expressed genes among a set of candidate normalization genes. The strategy is rooted in a mathematical model of gene expression that enables estimation not only of the overall variation of the candidate normalization genes but also of the variation between sample subgroups of the sample set.
Notably, the strategy provides a direct measure for the estimated expression variation, enabling the user to evaluate the systematic error introduced when using the gene. In a side-by-side comparison with a previously published strategy, our model-based approach performed in a more robust manner and showed less sensitivity toward coregulation of the candidate normalization genes. We used the model-based strategy to identify genes suited to normalize quantitative RT-PCR data from colon cancer and bladder cancer. These genes are UBC, GAPD, and TPT1 for the colon and HSPCB, TEGT, and ATP5B for the bladder. The presented strategy can be applied to evaluate the suitability of any normalization gene candidate in any kind of experimental design and should allow more reliable normalization of RT-PCR data.
cDNA from Human Adult Normal Tissue: Uterus: Fundus |
|||
| C1234278-10 | Biochain | 10 reactions | EUR 231 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Monkey (Rhesus) Normal Tissue: Uterus: Cervix |
|||
| C1534275 | Biochain | 40 reactions | EUR 540 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Monkey (Cynomolgus) Normal Tissue: Uterus: Cervix |
|||
| C1534275-Cy | Biochain | 40 reactions | EUR 540 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Monkey (Rhesus) Normal Tissue: Uterus: Corpus |
|||
| C1534276 | Biochain | 40 reactions | EUR 540 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Monkey (Rhesus) Normal Tissue: Uterus: Fundus |
|||
| C1534278 | Biochain | 40 reactions | EUR 540 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
Human Catalase (CAT) ELISA Kit |
|||
| DLR-CAT-Hu-48T | DL Develop | 48T | EUR 441 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Human Catalase (CAT) ELISA Kit |
|||
| DLR-CAT-Hu-96T | DL Develop | 96T | EUR 570 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Mouse Catalase (CAT) ELISA Kit |
|||
| DLR-CAT-Mu-48T | DL Develop | 48T | EUR 527 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Mouse Catalase (CAT) ELISA Kit |
|||
| DLR-CAT-Mu-96T | DL Develop | 96T | EUR 688 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Rat Catalase (CAT) ELISA Kit |
|||
| DLR-CAT-Ra-48T | DL Develop | 48T | EUR 549 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Rat Catalase (CAT) ELISA Kit |
|||
| DLR-CAT-Ra-96T | DL Develop | 96T | EUR 718 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
|||
Human Catalase (CAT) ELISA Kit |
|||
| RD-CAT-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 436 |
Human Catalase (CAT) ELISA Kit |
|||
| RD-CAT-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 601 |
Mouse Catalase (CAT) ELISA Kit |
|||
| RD-CAT-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 533 |
Mouse Catalase (CAT) ELISA Kit |
|||
| RD-CAT-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 740 |
Rat Catalase (CAT) ELISA Kit |
|||
| RD-CAT-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 557 |
Rat Catalase (CAT) ELISA Kit |
|||
| RD-CAT-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 775 |
Human Catalase (CAT) ELISA Kit |
|||
| RDR-CAT-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 455 |
Human Catalase (CAT) ELISA Kit |
|||
| RDR-CAT-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 629 |
Mouse Catalase (CAT) ELISA Kit |
|||
| RDR-CAT-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 557 |
Mouse Catalase (CAT) ELISA Kit |
|||
| RDR-CAT-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 774 |
Rat Catalase (CAT) ELISA Kit |
|||
| RDR-CAT-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 583 |
Rat Catalase (CAT) ELISA Kit |
|||
| RDR-CAT-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 811 |
Uterus Lysate |
|||
| 1317 | ProSci | 0.1 mg | EUR 191 |
|
Description: Uterus tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Uterus Tumor Lysate |
|||
| 1384 | ProSci | 0.1 mg | EUR 254 |
|
Description: Uterus tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
Fetal Uterus Lysate |
|||
| XBL-10431 | ProSci | 0.1 mg | EUR 527 |
|
Description: Fetal human uterus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human uterus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the uterus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The uterus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Uterus Membrane Lysate |
|||
| XBL-11023 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Bovine UTERUS 5 EA* |
|||
| 57153-2 | Pel-Freez | 5 EA | EUR 204.2 |
Human Uterus Tumor lysate |
|||
| HTL-1384 | Alpha Diagnostics | 1 mg | EUR 773 |
Uterus Tissue Slide (Normal) |
|||
| 11-401-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Normal) |
|||
| 11-401-4um | ProSci | 4 um | EUR 180.5 |
Uterus Tissue Slide (Benign) |
|||
| 11-402-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Benign) |
|||
| 11-402-4um | ProSci | 4 um | EUR 180.5 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| 11-404-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| 11-404-4um | ProSci | 4 um | EUR 180.5 |
Uterus Tissue Slide (Abnormal) |
|||
| 11-419-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Abnormal) |
|||
| 11-419-4um | ProSci | 4 um | EUR 180.5 |
Uterus Tissue Slide (Adenomyoma) |
|||
| 11-432-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Adenomyoma) |
|||
| 11-432-4um | ProSci | 4 um | EUR 180.5 |
Uterus Membrane Tumor Lysate |
|||
| XBL-11031 | ProSci | 0.1 mg | EUR 626.75 |
|
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Uterus-Corpus Membrane Lysate |
|||
| XBL-11037 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: Human uterus-corpus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-corpus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-corpus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-corpus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Uterus-Fundus Membrane Lysate |
|||
| XBL-11040 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: Human uterus-fundus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-fundus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-fundus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-fundus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Total RNA from Human Adult Normal Tissue: Uterus: Cervix of uterus |
|||
| R1234275-50 | Biochain | 50 ug | EUR 178 |
|
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
Total RNA from Human Adult Normal Tissue: Uterus: Corpus of Uterus |
|||
| R1234276-10 | Biochain | 10 ug | EUR 194 |
|
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
CAT/ Rat CAT ELISA Kit |
|||
| ELA-E0242r | Lifescience Market | 96 Tests | EUR 886 |
Rabbit UTERUS Y 25 EA* |
|||
| 41253-2 | Pel-Freez | 25 EA | EUR 318.39 |
Total RNA from Lupus: Uterus |
|||
| R1236274Lup-50 | Biochain | 50 ug | EUR 351 |
|
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
Uterus Tissue Slide (Endometrioid Adenocarcinoma) |
|||
| 11-405-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Endometrioid Adenocarcinoma) |
|||
| 11-405-4um | ProSci | 4 um | EUR 180.5 |
CAT Antibody |
|||
| 36312-100ul | SAB | 100ul | EUR 252 |
CAT siRNA |
|||
| 20-abx900807 | Abbexa |
|
|
CAT siRNA |
|||
| 20-abx910366 | Abbexa |
|
|
CAT siRNA |
|||
| 20-abx910367 | Abbexa |
|
|
CAT Antibody |
|||
| 1-CSB-PA070043 | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/20000 |
|||
CAT Antibody |
|||
| 1-CSB-PA599838 | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200 |
|||
CAT Antibody |
|||
| 1-CSB-PA942303 | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:50-1:200 |
|||
CAT Antibody |
|||
| 1-CSB-PA004980 | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
CAT Antibody |
|||
| 1-CSB-PA004563GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
pCas9- CAT |
|||
| PVT11001 | Lifescience Market | 2 ug | EUR 301 |
pOTB7-CAT |
|||
| PVT18217 | Lifescience Market | 2 ug | EUR 231 |
CAT antibody |
|||
| 10R-3584 | Fitzgerald | 100 ul | EUR 726 |
|
Description: Mouse monoclonal CAT antibody |
|||
CAT antibody |
|||
| 10R-3585 | Fitzgerald | 100 ul | EUR 691 |
|
Description: Mouse monoclonal CAT antibody |
|||
CAT antibody |
|||
| 70R-16187 | Fitzgerald | 50 ul | EUR 435 |
|
Description: Rabbit polyclonal CAT antibody |
|||
CAT antibody |
|||
| 20C-CR1111RP | Fitzgerald | 500 ul | EUR 262 |
|
Description: Rabbit polyclonal CAT antibody |
|||
Cat IgM |
|||
| 31C-CH0213 | Fitzgerald | 1 mg | EUR 392 |
|
Description: Purified Cat IgM |
|||
Total RNA from Human Adult Normal Tissue 5 Donor Pool: Uterus: Cervix of uterus |
|||
| R1234275-P | Biochain | 50 ug | EUR 328 |
|
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA Synthesis SuperMix |
|||
| 20-abx09801420ulSystems | Abbexa |
|
|
Novo? cDNA Kit |
|||
| M1165-100 | Biovision | EUR 354 | |
Novo? cDNA Kit |
|||
| M1165-25 | Biovision | EUR 267 | |
Evo? cDNA Supermix |
|||
| M1168-100 | Biovision | EUR 381 | |
Evo? cDNA Supermix |
|||
| M1168-25 | Biovision | EUR 267 | |
Novo? cDNA Supermix |
|||
| M1169-100 | Biovision | EUR 441 | |
Novo? cDNA Supermix |
|||
| M1169-25 | Biovision | EUR 289 | |
Frozen Tissue Section - Human Tumor: Uterus |
|||
| T1235274 | Biochain | 5 slides | EUR 338 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
Uterus Tissue Slide ( Papillary serous Adenocarcinoma) |
|||
| 11-407-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide ( Papillary serous Adenocarcinoma) |
|||
| 11-407-4um | ProSci | 4 um | EUR 180.5 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| 11-418-10um | ProSci | 10 um | EUR 201.5 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| 11-418-4um | ProSci | 4 um | EUR 180.5 |
cDNA from Plant Normal Tissue: cDNA from Plant: Arabidopsis |
|||
| C1634310 | Biochain | 40 reactions | EUR 621 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Plant Normal Tissue: cDNA from Plant: Corn |
|||
| C1634330 | Biochain | 40 reactions | EUR 621 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Plant Normal Tissue: cDNA from Plant: Orange |
|||
| C1634340 | Biochain | 40 reactions | EUR 621 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Plant Normal Tissue: cDNA from Plant: Potato |
|||
| C1634350 | Biochain | 40 reactions | EUR 621 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Plant Normal Tissue: cDNA from Plant: Rice |
|||
| C1634360 | Biochain | 40 reactions | EUR 621 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
cDNA from Plant Normal Tissue: cDNA from Plant: Wheat |
|||
| C1634390 | Biochain | 40 reactions | EUR 621 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
PKA CAT Antibody |
|||
| abx147539-100ug | Abbexa | 100 ug | EUR 439 |
Catalase (CAT) Antibody |
|||
| 20-abx132110 | Abbexa |
|
|
Catalase (CAT) Antibody |
|||
| 20-abx132122 | Abbexa |
|
|
Catalase (CAT) Antibody |
|||
| 20-abx125619 | Abbexa |
|
|
Catalase (CAT) Antibody |
|||
| 20-abx125620 | Abbexa |
|
|
Catalase (CAT) Antibody |
|||
| 20-abx111432 | Abbexa |
|
|
CAT Rabbit pAb |
|||
| A11777-100ul | Abclonal | 100 ul | EUR 308 |
CAT Rabbit pAb |
|||
| A11777-200ul | Abclonal | 200 ul | EUR 459 |
CAT Rabbit pAb |
|||
| A11777-20ul | Abclonal | 20 ul | EUR 183 |
CAT Rabbit pAb |
|||
| A11777-50ul | Abclonal | 50 ul | EUR 223 |